307 related articles for article (PubMed ID: 36202498)
1. Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century.
Alicic R; Nicholas SB
Mayo Clin Proc; 2022 Oct; 97(10):1904-1919. PubMed ID: 36202498
[TBL] [Abstract][Full Text] [Related]
2. Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials.
Gohda T; Murakoshi M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430228
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk.
Stephens JW; Brown KE; Min T
Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():32-45. PubMed ID: 32267078
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.
Wang N; Zhang C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542060
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy for kidney disease in people with diabetes mellitus.
van Raalte DH; Bjornstad P; Cherney DZI; de Boer IH; Fioretto P; Gordin D; Persson F; Rosas SE; Rossing P; Schaub JA; Tuttle K; Waikar SS; Heerspink HJL
Nat Rev Nephrol; 2024 Jul; 20(7):433-446. PubMed ID: 38570632
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
Helou N; Dwyer A; Shaha M; Zanchi A
JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
Scheen AJ
Diabetes Metab; 2019 Apr; 45(2):110-121. PubMed ID: 30477733
[TBL] [Abstract][Full Text] [Related]
8. Present and future directions in diabetic kidney disease.
Limonte CP; Kretzler M; Pennathur S; Pop-Busui R; de Boer IH
J Diabetes Complications; 2022 Dec; 36(12):108357. PubMed ID: 36403478
[TBL] [Abstract][Full Text] [Related]
9. Diabetic kidney disease: a report from an ADA Consensus Conference.
Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
Diabetes Care; 2014 Oct; 37(10):2864-83. PubMed ID: 25249672
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid Antagonism and Diabetic Kidney Disease.
Lytvyn Y; Godoy LC; Scholtes RA; van Raalte DH; Cherney DZ
Curr Diab Rep; 2019 Jan; 19(1):4. PubMed ID: 30673886
[TBL] [Abstract][Full Text] [Related]
11. A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches.
Mima A
Adv Ther; 2022 Aug; 39(8):3488-3500. PubMed ID: 35751762
[TBL] [Abstract][Full Text] [Related]
12. Diabetic Kidney Disease.
Bonner R; Albajrami O; Hudspeth J; Upadhyay A
Prim Care; 2020 Dec; 47(4):645-659. PubMed ID: 33121634
[TBL] [Abstract][Full Text] [Related]
13. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
de Boer IH; Khunti K; Sadusky T; Tuttle KR; Neumiller JJ; Rhee CM; Rosas SE; Rossing P; Bakris G
Kidney Int; 2022 Nov; 102(5):974-989. PubMed ID: 36202661
[TBL] [Abstract][Full Text] [Related]
14. Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease.
Mima A
J Diabetes Complications; 2018 Jul; 32(7):720-725. PubMed ID: 29880432
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
Barrera-Chimal J; Jaisser F
Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease.
Górriz JL; Navarro-González JF; Ortiz A; Vergara A; Nuñez J; Jacobs-Cachá C; Martínez-Castelao A; Soler MJ
Nephrol Dial Transplant; 2020 Jan; 35(Suppl 1):i13-i23. PubMed ID: 32003834
[TBL] [Abstract][Full Text] [Related]
17. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
Zanchi A; Jehle AW; Lamine F; Vogt B; Czerlau C; Bilz S; Seeger H; de Seigneux S
Swiss Med Wkly; 2023 Jan; 153():40004. PubMed ID: 36652726
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
Karalliedde J; Winocour P; Chowdhury TA; De P; Frankel AH; Montero RM; Pokrajac A; Banerjee D; Dasgupta I; Fogarty D; Sharif A; Wahba M; Mark PB; Zac-Varghese S; Patel DC; Bain SC
Diabet Med; 2022 Apr; 39(4):e14769. PubMed ID: 35080257
[TBL] [Abstract][Full Text] [Related]
19. Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention.
McGrath K; Edi R
Am Fam Physician; 2019 Jun; 99(12):751-759. PubMed ID: 31194487
[TBL] [Abstract][Full Text] [Related]
20. Diabetic kidney disease: a report from an ADA Consensus Conference.
Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
